partnering

News

Boehringer puts IBM's GenAI into its antibody discovery tank

In another example of the pharma industry embracing generative artificial intelligence (GenAI), Boehringer Ingelheim will use technology developed by IBM to rev up antibody discovery

News

Sosei sees $3bn sales potential for GSK's IBD discard

Sosei Heptares has lost GSK as a partner for an inflammatory bowel disease (IBD) drug candidate GSK4381406, but says it will take the programme forward as it has significa

News

Autifony swings $770.5m deal with Jazz for CNS drugs

UK biotech Autifony has signed an exclusive licensing deal with Jazz Pharmaceuticals, giving the Ireland-headquartered drugmaker global rights to a pair of ion channel tar

News

Bayer pledges up to $1.5bn for Recursion oncology alliance

Bayer has restructured and expanded its ongoing partnership with Recursion Pharmaceuticals on artificial intelligence-powered drug discovery, switching to a focus on cance

News

BioNTech flashes the cash, adding tumour drug in $1bn deal

Fresh from slashing its predictions for COVID-19 vaccine sales this year, mRNA specialist BioNTech has used some of its extensive cash reserves to bolster its pipeline in

News

BMS extends its position in ADCs with $180m Orum deal

Bristol-Myers Squibb has signed another deal to build its capabilities in antibody-drug conjugates for cancer, paying $100 million upfront to take control of an Orum Thera

Boehringer puts IBM's GenAI into its antibody discovery tank

Sosei sees $3bn sales potential for GSK's IBD discard

Autifony swings $770.5m deal with Jazz for CNS drugs

Bayer pledges up to $1.5bn for Recursion oncology alliance

BioNTech flashes the cash, adding tumour drug in $1bn deal

BMS extends its position in ADCs with $180m Orum deal

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

partnering

Editor's Picks